Eikon Therapeutics, Inc. Common Stock
$8.51
-$0.98 (-10.33%)
$8.39Day Range$9.64
Key Statistics
Market Cap
$460.94M
Shares Outstanding
54.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 5, 2026
Round Lot
100
Locale
US
Trading Data
Day Open
$9.47
Day High
$9.64
Day Low
$8.39
Volume
989.4K
VWAP
$8.72
Prev Close
$9.49
Transactions
--
Acc. Volume
--
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836384 employees230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030341-777-0566IPO Feb 5, 2026US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001861123
- Composite FIGI
- BBG00T0XRJ75
- Share Class FIGI
- BBG00T0XRJ84
- Ticker Root
- EIKN
- SIC Code
- 2836
About Eikon Therapeutics, Inc. Common Stock (EIKN) Stock
Eikon Therapeutics, Inc. Common Stock (EIKN) closed the 2026-09-16 session at $8.51, down 10.33% versus the previous close (-0.98). The stock opened at $9.47 and traded between $8.39 and $9.64 during that session. Session trading volume was 989K shares. The volume-weighted average price (VWAP) is $8.72.
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Eikon Therapeutics, Inc. Common Stock has a market capitalization of $460.9 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. EIKN is listed on the XNAS exchange. The company employs approximately 384 people. Eikon Therapeutics, Inc. Common Stock is headquartered in MILLBRAE, CA. The recorded listing date is 2026-02-05.
On this page you can find market EIKN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.